Product Discontinuation Notice

Dear Customer,

after careful consideration, QIAGEN has decided to discontinue the production of the aLF Reader with May 30, 2021 as final date of order placement and June 30, 2021 as final date of delivery. We will continue to provide lifecycle and service support until June 30, 2026.

While we regret any inconvenience this announcement may cause, we are pleased to supply you with alternate reader solutions for rapid testing from our subsidiary company DIALUNOX GmbH. Feel free to contact us for further questions.

Accepting Submissions for the Rapid Testing Innovation Award

QIAGEN Lake Constance and DCN Dx are now accepting proposals for the First Rapid Testing Innovation Award, to be presented at the 2018 Advanced Lateral Flow Course in October. This competitive prize includes a cash award of $10,000 and will recognize the best innovation to the field of rapid point-of-care assays or the most novel application for rapid assays during the past year.

Solicitations are invited from academic, government or corporate individuals or groups, subject to the regulations of the institutions employing those individuals and groups, which demonstrate a novel innovation or application for point-of-care tests.

To apply, please follow this link.